Glycemia in Diabetic Elders Trial
| Status: | Terminated |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 65 - Any |
| Updated: | 4/17/2018 |
| Start Date: | April 2013 |
| End Date: | February 2017 |
This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients
conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology
Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen
base solely on traditional drugs, a regimen including newer drugs will achieve glycemic
target faster and induce less hypoglycemia, weight gain, and other side effects, over the
short run.
conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology
Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen
base solely on traditional drugs, a regimen including newer drugs will achieve glycemic
target faster and induce less hypoglycemia, weight gain, and other side effects, over the
short run.
Inclusion Criteria:
- Type 2 diabetics diagnosed for at least 6 months
- Patients ages ≥ 65 years and older
- Active patients in the Bay West Endocrinology practice
- Inadequately controlled on oral agents and/or basal insulin with HbA1c between 8.0%
and 12%
- Eligible for randomization to either treatment group
- Patients willing to follow either treatment arm including regimen using one or more
injectables
- Patients to have an English Reading Level of Grade 6 or above
- Patients residing at home
Exclusion Criteria:
- Unwilling to use a regimen that may contain using one or more injections
- Using short acting insulin prior to the study
- Using GLP-1 in past 10 weeks
- History of hypoglycemia unawareness or episodes needing emergency intervention
- End-stage renal disease
- Dementia
- Blindness
- Terminal illness
We found this trial at
1
site
Click here to add this to my saved trials
